ERBB2 and breast cancer: HER2, which is encoded by the ERBB2 gene, and HER2‐E BC has the highest ERBB2 mRNA expression, HER2 protein over‐expression, and is associated with higher pathologic complete response (pCR) rates following anti‐HER2‐based regimens [3, 6, 7, 8, 9].